1[1]Lauer GM,Walker BD.Hepatitis C virus infection.N Engl J Med 2001; 345:41-52.
2[2]Alter MJ,Kruszon-Moran D,Nainan OV,McQuillan GM,Gao F,Moyer LA,Kaslow RA,Margolis HS.The prevalence of hepatitis C virus infection in the United States,1988 through 1994.N Engl J Med 1999; 341:556-562
3[3]Curry MP.Hepatitis B and hepatitis C viruses in liver transplantation.Transplantation 2004; 78:955-963
4[4]Vargas HE,Laskus T,Radkowski M,Wilkinson J,Balan V,Douglas DD,Harrison ME,Mulligan DC,Olden K,Adair D,Rakela J.Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation.Liver Transpl 2002; 8:1014-1019
5[5]Yan FM,Chen AS,Hao F,Zhao XP,Gu CH,Zhao LB,Yang DL,Hao LJ.Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.World J Gastroenterol 2000; 6:805-811
6[6]Lamelin JP,Zoulim F,Trepo C.Lymphotropism of hepatitis B and C viruses:an update and a newcomer.Int J Clin Lab Res 1995; 25:1-6
7[7]Gruener NH,Jung MC,Schirren CA.Recurrent hepatitis C virus infection after liver transplantation:natural course,therapeutic approach and possible mechanisms of viral control.J Antimicrob Chemother 2004; 54:17-20
8[8]Porter SB,Reddy KR.Factors that influence the severity of recurrent hepatitis C virus following liver transplantation.Clin Liver Dis 2003; 7:603-614
9[9]Prieto M,Berenguer M,Rayon JM,Cordoba J,Arguello L,Carrasco D,Garcia-Herola A,Olaso V,De Juan M,Gobernado M,Mir J,Berenguer J.High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation:relationship with rejection episodes.Hepatology 1999; 29:250-256
10[10]Forman LM,Lewis JD,Berlin JA,Feldman HI,Lucey MR.The association between hepatitis C infection and survival after orthotopic liver transplantation.Gastroenterology 2002; 122:889-896
8Ali T, Miner PB. New development in gastroesophageal reflux disease diagnosis and therapy[J]. Curr Opin Gas- troenterol, 2008,24 (4) : 502-508.
9Stewart WF, Liberman JN, Sandier RS, et al. Epidemiology of con2stipation study in the United States : relation of clinical sub- types to sociodemographic features. Am J Gastroenterol, 1999,94 (12):3530-3540.
10De Schryver AM, Andriesse GI, Samsom M, et al. The effects of thespecific 5HT4 receptor agonist, prucalopride, on colonicmo-tility inhealthy volunteers. Alim Pharm Ther, 2002,2(16):603-4512.
